89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 70 filers reported holding 89BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,088,520 | +563.1% | 70,500 | +554.0% | 0.03% | +766.7% |
Q1 2023 | $164,164 | -85.4% | 10,779 | -87.8% | 0.00% | -88.5% |
Q4 2022 | $1,127,051 | +444.5% | 88,535 | +147.6% | 0.03% | +420.0% |
Q3 2022 | $207,000 | -79.4% | 35,760 | -8.6% | 0.01% | -91.8% |
Q3 2020 | $1,003,000 | – | 39,104 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |